Last Price
71.27
Today's Change
+1.07 (1.52%)
Day's Change
69.86 - 71.54
Trading Volume
433,963
Overview
Market Cap
13 Billion
Shares Outstanding
180 Million
Avg Volume
1,952,995
Avg Price (50 Days)
76.03
Avg Price (200 Days)
73.81
PE Ratio
-13.04
EPS
-5.57
Earnings Announcement
07-May-2025
Previous Close
70.20
Open
69.92
Day's Range
69.86 - 72.66
Year Range
21.92 - 84.91
Trading Volume
1,472,160
Price Change Highlight
1 Day Change
3.49%
5 Day Change
3.85%
1 Month Change
-7.77%
3 Month Change
-5.34%
6 Month Change
-2.54%
Ytd Change
3.86%
1 Year Change
201.33%
3 Year Change
190.25%
5 Year Change
256.30%
10 Year Change
214.77%
Max Change
-55.97%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
.png)
Apps
Top Articles
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
